Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7–induced signaling

Thymic stromal lymphopoietin (TSLP) is a type I cytokine that plays essential roles in allergic/inflammatory skin and airway disorders, in helminth infections, and in regulating intestinal immunity. TSLP signals via IL-7Rα and a specific TSLPR subunit that is highly related to the common cytokine receptor γ chain, γc. Although TSLP has effects on a broad range of hematopoetic cells and can induce STAT5 phosphorylation, TSLP was reported to not signal via JAK kinases, and the mechanism by which TSLP regulates STAT5 phosphorylation has been unclear. We now demonstrate the role of JAK1 and JAK2 in TSLP-mediated STAT5 phosphorylation in mouse and human primary CD4+ T cells, in contrast to the known activation of JAK1 and JAK3 by the related cytokine, IL-7. We also show that just as JAK1 interacts with IL-7Rα, JAK2 is associated with TSLPR protein. Moreover, we demonstrate the importance of STAT5 activation for TSLP-mediated survival and proliferation of CD4+ T cells. These findings clarify the basis for TSLP-mediated signaling and provide an example wherein a cytokine uses JAK1 and JAK2 to mediate the activation of STAT5.

[1]  W. Tse,et al.  STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease. , 2009, Blood.

[2]  R. Meier,et al.  Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function , 2009, Proceedings of the National Academy of Sciences.

[3]  W. Leonard,et al.  New insights into the regulation of T cells by γc family cytokines , 2009, Nature Reviews Immunology.

[4]  S. Ziegler,et al.  Regulation of Helminth-Induced Th2 Responses by Thymic Stromal Lymphopoietin1 , 2009, The Journal of Immunology.

[5]  Yu Wang,et al.  TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis , 2009, The Journal of experimental medicine.

[6]  D. Artis,et al.  TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis , 2009, The Journal of experimental medicine.

[7]  W. Leonard,et al.  The Role of Thymic Stromal Lymphopoietin in CD8+ T Cell Homeostasis1 , 2008, The Journal of Immunology.

[8]  W. Leonard,et al.  Thymic stromal lymphopoietin: a new cytokine in asthma. , 2008, Current opinion in pharmacology.

[9]  D. Lauffenburger,et al.  Interleukin-7 Receptor Signaling Network: An Integrated Systems Perspective , 2008, Cellular and Molecular Immunology.

[10]  Ruslan Medzhitov,et al.  A mechanism for the initiation of allergen-induced T helper type 2 responses , 2008, Nature Immunology.

[11]  A. Rolink,et al.  Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice. , 2007, Blood.

[12]  W. Leonard,et al.  Cutting Edge: Direct Action of Thymic Stromal Lymphopoietin on Activated Human CD4+ T Cells , 2007, The Journal of Immunology.

[13]  Tomoki Ito,et al.  TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. , 2007, Annual review of immunology.

[14]  S. Ziegler,et al.  Induction of IL-4 Expression in CD4+ T Cells by Thymic Stromal Lymphopoietin1 , 2007, The Journal of Immunology.

[15]  S. Ziegler,et al.  Thymic stromal lymphopoietin in normal and pathogenic T cell development and function , 2006, Nature Immunology.

[16]  Xianyue Ma,et al.  Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of Jak2 tyrosine kinase autophophorylation , 2005 .

[17]  B. O'connor,et al.  Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. , 2005, Journal of immunology.

[18]  C. Deng,et al.  Inactivation of Stat5 in Mouse Mammary Epithelium during Pregnancy Reveals Distinct Functions in Cell Proliferation, Survival, and Differentiation , 2004, Molecular and Cellular Biology.

[19]  A. Pandey,et al.  A Role for Thymic Stromal Lymphopoietin in CD4+ T Cell Development , 2004, The Journal of experimental medicine.

[20]  H. Young,et al.  Distinct Regions of the Interleukin-7 Receptor Regulate Different Bcl2 Family Members , 2004, Molecular and Cellular Biology.

[21]  H. Rui,et al.  Impaired Alveologenesis and Maintenance of Secretory Mammary Epithelial Cells in Jak2 Conditional Knockout Mice , 2004, Molecular and Cellular Biology.

[22]  S. Ziegler,et al.  Absence of an Essential Role for Thymic Stromal Lymphopoietin Receptor in Murine B-Cell Development , 2004, Molecular and Cellular Biology.

[23]  C. Schindler,et al.  Series Introduction: JAK-STAT signaling in human disease , 2002 .

[24]  S. Ziegler,et al.  Uncoupling of Proliferation and Stat5 Activation in Thymic Stromal Lymphopoietin-Mediated Signal Transduction1 , 2002, The Journal of Immunology.

[25]  Heinz Baumann,et al.  Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin , 2000, Nature Immunology.

[26]  A. Iwama,et al.  Molecular cloning and characterization of CRLM-2, a novel type I cytokine receptor preferentially expressed in hematopoietic cells. , 2000, Biochemical and biophysical research communications.

[27]  N. Copeland,et al.  Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain. , 2000, Blood.

[28]  S. Ziegler,et al.  Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. , 1999, Journal of immunology.

[29]  R. Perlmutter,et al.  Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. , 1999, Journal of immunology.

[30]  Steven F. Ziegler,et al.  Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.

[31]  R. Schreiber,et al.  Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.

[32]  A. Yoshimura,et al.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.

[33]  W. Leonard,et al.  Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.

[34]  J. Johnston,et al.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) , 1995, Nature.

[35]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[36]  W. Leonard,et al.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. , 1995, Immunity.

[37]  A. Shaw,et al.  The Conserved Box 1 Motif of Cytokine Receptors Is Required for Association with JAK Kinases (*) , 1995, The Journal of Biological Chemistry.

[38]  J. Gribben,et al.  Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. , 1994, Science.

[39]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[40]  O. Silvennoinen,et al.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.

[41]  S. Nishikawa,et al.  Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. , 1994, Science.

[42]  D. Williams,et al.  A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. , 1994, Experimental hematology.

[43]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[44]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[45]  Xianyue Ma,et al.  Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. , 2005, Journal of medicinal chemistry.

[46]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.